| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $156.4M | +47.4% | +54.8% |
| R&D Expense | $15.9M | -0.6% | -1.0% |
| SG&A Expense | $36.4M | +121.8% | +128.9% |
| Operating Income | $52.7M | +90.2% | +101.7% |
| Pre-tax Income | $58.4M | +75.0% | +103.5% |
| Income Tax | -$31.5M | -1037.2% | -2611.0% |
| Net Income | $89.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.10B | — | — |
| Accounts Receivable | $46.2M | — | — |
| Current Assets | $1.76B | — | — |
| Total Assets | $2.16B | — | — |
| Current Liabilities | $778.2M | — | — |
| Long-term Debt | $466.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $49.3M | — | — |
| Investing Cash Flow | -$20.8M | — | — |
| Financing Cash Flow | $788.2M | — | — |
| +199.2% |
| +227.6% |
| EPS (Basic) | $0.42 | +281.8% | +366.7% |
| EPS (Diluted) | $0.34 | +325.0% | +277.8% |
| — |
| Total Liabilities | $980.2M | — | — |
| Stockholders' Equity | $1.17B | +188.7% | +234.1% |